Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Voriconazole-Induced Hepatitis via Simvastatin- and Lansoprazole-Mediated Drug Interactions: A Case Report and Review of the Literature.

Lopez JL, Tayek JA.

Drug Metab Dispos. 2016 Jan;44(1):124-6. doi: 10.1124/dmd.115.066878. Epub 2015 Oct 26. Review.

2.

Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing.

Shah A, Miller CJ, Nast CC, Adams MD, Truitt B, Tayek JA, Tong L, Mehtani P, Monteon F, Sedor JR, Clinkenbeard EL, White K, Mehrotra R, LaPage J, Dickson P, Adler SG, Iyengar SK.

Nephrol Dial Transplant. 2014 Dec;29(12):2235-43. doi: 10.1093/ndt/gfu324. Epub 2014 Nov 5.

3.

Prevalence and severity of coronary artery calcium in young persons with diabetes.

Daga N, Nasir K, Hamirani Y, Tayek J, Bach P, Li D, Budoff MJ.

J Cardiovasc Comput Tomogr. 2013 Jul-Aug;7(4):241-7. doi: 10.1016/j.jcct.2013.08.004. Epub 2013 Aug 22.

PMID:
24148777
4.

Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial.

Rattanasompattikul M, Molnar MZ, Lee ML, Dukkipati R, Bross R, Jing J, Kim Y, Voss AC, Benner D, Feroze U, Macdougall IC, Tayek JA, Norris KC, Kopple JD, Unruh M, Kovesdy CP, Kalantar-Zadeh K.

J Cachexia Sarcopenia Muscle. 2013 Dec;4(4):247-57. doi: 10.1007/s13539-013-0115-9. Epub 2013 Sep 20.

5.

The extinguished BEACON of bardoxolone: not a Monday morning quarterback story.

Tayek JA, Kalantar-Zadeh K.

Am J Nephrol. 2013;37(3):208-11. doi: 10.1159/000346950. Epub 2013 Feb 28. No abstract available. Erratum in: Am J Nephrol. 2013;37(5):507.

6.

Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature.

Patel SS, Molnar MZ, Tayek JA, Ix JH, Noori N, Benner D, Heymsfield S, Kopple JD, Kovesdy CP, Kalantar-Zadeh K.

J Cachexia Sarcopenia Muscle. 2013 Mar;4(1):19-29. doi: 10.1007/s13539-012-0079-1. Epub 2012 Jul 10.

7.

Identification of noncalcified plaque in young persons with diabetes: an opportunity for early primary prevention of coronary artery disease identified with low-dose coronary computed tomographic angiography.

Madaj PM, Budoff MJ, Li D, Tayek JA, Karlsberg RP, Karpman HL.

Acad Radiol. 2012 Jul;19(7):889-93. doi: 10.1016/j.acra.2012.03.013. Epub 2012 Apr 26.

8.

Diabetes patients and non-diabetic patients intensive care unit and hospital mortality risks associated with sepsis.

Tayek CJ, Tayek JA.

World J Diabetes. 2012 Feb 15;3(2):29-34. doi: 10.4239/wjd.v3.i2.29.

9.

Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.

Bostrom MA, Kao WH, Li M, Abboud HE, Adler SG, Iyengar SK, Kimmel PL, Hanson RL, Nicholas SB, Rasooly RS, Sedor JR, Coresh J, Kohn OF, Leehey DJ, Thornley-Brown D, Bottinger EP, Lipkowitz MS, Meoni LA, Klag MJ, Lu L, Hicks PJ, Langefeld CD, Parekh RS, Bowden DW, Freedman BI; Family Investigation of Nephropathy and Diabetes (FIND) Research Group..

Am J Kidney Dis. 2012 Feb;59(2):210-21. doi: 10.1053/j.ajkd.2011.09.020. Epub 2011 Nov 25.

10.

Examination of association with candidate genes for diabetic nephropathy in a Mexican American population.

Kim S, Abboud HE, Pahl MV, Tayek J, Snyder S, Tamkin J, Alcorn H Jr, Ipp E, Nast CC, Elston RC, Iyengar SK, Adler SG.

Clin J Am Soc Nephrol. 2010 Jun;5(6):1072-8. doi: 10.2215/CJN.06550909. Epub 2010 Mar 18.

11.

Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial.

Gerstein HC, Ratner RE, Cannon CP, Serruys PW, García-García HM, van Es GA, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW; APPROACH Study Group..

Circulation. 2010 Mar 16;121(10):1176-87. doi: 10.1161/CIRCULATIONAHA.109.881003. Epub 2010 Mar 1.

12.

Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis.

McKinnell J, Tayek JA.

J Clin Rheumatol. 2009 Sep;15(6):303-5. doi: 10.1097/RHU.0b013e3181bbbcd7.

PMID:
19734738
13.
14.

Serum albumin concentration and waiting list mortality in idiopathic interstitial pneumonia.

Zisman DA, Kawut SM, Lederer DJ, Belperio JA, Lynch JP 3rd, Schwarz MI, Tayek JA, Reuben DB, Karlamangla AS.

Chest. 2009 Apr;135(4):929-35. doi: 10.1378/chest.08-0754. Epub 2008 Nov 18.

15.

Adrenal insufficiency: relative, classical or critical?

Tayek J.

Acta Anaesthesiol Scand. 2008 Sep;52(8):1168-9. doi: 10.1111/j.1399-6576.2008.01708.x. No abstract available.

PMID:
18840121
16.

SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics.

Tayek J.

Diabetes Obes Metab. 2008 Nov;10(11):1128-9; author reply 1129-30. doi: 10.1111/j.1463-1326.2008.00928.x. Epub 2008 Jul 29. No abstract available.

PMID:
18671799
17.

Lipophilicity and cardiovascular outcome in patients with CHF.

Ford JS, Tayek JA.

Am Heart J. 2008 Aug;156(2):e7; author reply e9. doi: 10.1016/j.ahj.2008.04.025. Epub 2008 Jul 7. No abstract available.

PMID:
18657645
18.

Stents versus bypass grafting for left main coronary artery disease.

Tayek JA.

N Engl J Med. 2008 Jul 24;359(4):424; author reply 425. No abstract available.

PMID:
18655244
19.

Multifactorial intervention and mortality in type 2 diabetes.

Tayek JA.

N Engl J Med. 2008 May 22;358(21):2292; author reply 2292-3. No abstract available.

PMID:
18504827
20.

Early hyperglycemia and intravenous insulin.

Tayek JA.

Neurocrit Care. 2008;9(3):409-10. doi: 10.1007/s12028-008-9078-7. No abstract available.

PMID:
18363041

Supplemental Content

Loading ...
Support Center